|
|
First-Time Generic Approvals: Procardia XL, Estrostep FE, Estrostep
|
| Link ID |
1443 |
| Title |
First-Time Generic Approvals: Procardia XL, Estrostep FE, Estrostep |
| Url |
http://www.medscape.com/viewarticle/567110?src=rss |
| Description |
The FDA has approved first-time generic formulations for nifedipine extended-release tablets in 90-mg strength; norethindrone acetate and ethinyl estradiol tablets (28-day) in 1 mg/0.02 mg, 1 mg/0.03 mg, and 1 mg/0.035 mg strengths; and norethindrone acetate and ethinyl estradiol tablets (21-day) in 1 mg/0.02 mg, 1 mg/0.03 mg, and 1 mg/0.035 mg strengths. Medscape Medical News |
| Category |
Articles > Pharmacists |
| Keywords |
|
| Date |
Dec 8, 2007 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > Pharmacists |
| 2. |
Adalimumab May Stop Bone Loss With Rheumatoid Arthritis
|
|
|
Treatment with the anti-tumor necrosis factor antibody adalimumab may arrest bone loss in patients with rheumatoid arthritis, according to study results reported in the March issue of the Annals of the Rheumatic Diseases. Reuters Health Information
|
|
|
